Literature DB >> 21835476

Is the skin barrier abnormal in dogs with atopic dermatitis?

Thierry Olivry1.   

Abstract

In mammalian skin, the stratum corneum exerts a barrier function that protects from transepidermal water loss and the penetration of exogenous molecules, such as allergens, from the environment. Recently, skin barrier defects have been shown to be of prime importance in the pathogenesis of human atopic dermatitis. In this review, we summarize the latest research data pertinent to the stratum corneum and barrier function of dogs with atopic dermatitis. At the time of this writing, there is increasing evidence that a skin barrier defect likely exists in dogs with atopic dermatitis. This barrier dysfunction is characterized by abnormal intercellular stratum corneum lipid lamellae, abnormal stratum corneum morphology, reduced and abnormal ceramide content and, in some but not all dogs, abnormal filaggrin expression. In association with these changes, there is higher transepidermal water loss in atopic than in normal canine skin. Furthermore, atopic inflammation appears to worsen transepidermal water loss and filaggrin expression. It remains unknown, however, if the changes observed are primary (i.e. of genetic origin) or secondary to atopic inflammation that also exists even in clinically normal skin. Finally, whether or not a therapeutic intervention aimed at restoring a dysfunctional skin barrier is of any clinical benefit to atopic dogs has not yet been proven unequivocally.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21835476     DOI: 10.1016/j.vetimm.2011.07.014

Source DB:  PubMed          Journal:  Vet Immunol Immunopathol        ISSN: 0165-2427            Impact factor:   2.046


  12 in total

1.  Refinement of the canine CD1 locus topology and investigation of antibody binding to recombinant canine CD1 isoforms.

Authors:  Mette Schjaerff; Stefan M Keller; Joseph Fass; Lutz Froenicke; Robert A Grahn; Leslie Lyons; Verena K Affolter; Annemarie T Kristensen; Peter F Moore
Journal:  Immunogenetics       Date:  2015-12-21       Impact factor: 2.846

2.  Investigation of the Mechanism of Impaired Skin Barrier Function in Dogs With Malignant Tumors.

Authors:  Migyeong Geum; Ha-Jung Kim
Journal:  In Vivo       Date:  2022 Mar-Apr       Impact factor: 2.155

3.  A moisturizer formulated with glycerol and propylene glycol accelerates the recovery of skin barrier function after experimental disruption in dogs.

Authors:  Pauline Panzuti; Emilie Vidémont; Oscar Fantini; Lucile Fardouet; Guillaume Noël; Julien Cappelle; Didier Pin
Journal:  Vet Dermatol       Date:  2020-07-06       Impact factor: 1.589

4.  An explorative study comparing skin surface lipids in the West Highland white terrier dog with and without atopic dermatitis.

Authors:  Helen L Orbell; Nick J Cave; Katharina Parry; Craig E Griffin
Journal:  Vet Q       Date:  2022-12       Impact factor: 3.320

5.  Enhanced In Vitro Expression of Filaggrin and Antimicrobial Peptides Following Application of Glycosaminoglycans and a Sphingomyelin-Rich Lipid Extract.

Authors:  Sergi Segarra; Tanesha Naiken; Julien Garnier; Valérie Hamon; Nathalie Coussay; François-Xavier Bernard
Journal:  Vet Sci       Date:  2022-06-27

6.  The effect of Psoroptes ovis infestation on ovine epidermal barrier function.

Authors:  Miriam R Stoeckli; Tom N McNeilly; David Frew; Edward J Marr; Alasdair J Nisbet; Adri H M van den Broek; Stewart T G Burgess
Journal:  Vet Res       Date:  2013-02-11       Impact factor: 3.683

7.  Increased levels of palmitoylethanolamide and other bioactive lipid mediators and enhanced local mast cell proliferation in canine atopic dermatitis.

Authors:  Francesca Abramo; Luca Campora; Francesco Albanese; Maria Federica della Valle; Luigia Cristino; Stefania Petrosino; Vincenzo Di Marzo; Vincenzo Miragliotta
Journal:  BMC Vet Res       Date:  2014-01-14       Impact factor: 2.741

8.  Canine epidermal lipid sampling by skin scrub revealed variations between different body sites and normal and atopic dogs.

Authors:  Mandy Angelbeck-Schulze; Reinhard Mischke; Karl Rohn; Marion Hewicker-Trautwein; Hassan Y Naim; Wolfgang Bäumer
Journal:  BMC Vet Res       Date:  2014-07-10       Impact factor: 2.741

9.  Filaggrin silencing by shRNA directly impairs the skin barrier function of normal human epidermal keratinocytes and then induces an immune response.

Authors:  N N Dang; S G Pang; H Y Song; L G An; X L Ma
Journal:  Braz J Med Biol Res       Date:  2014-11-14       Impact factor: 2.590

10.  Canine Epidermal Keratinocytes (CPEK) Grown in Monolayer Are Not Representative of Normal Canine Keratinocytes for Permeability Studies: Pilot Studies.

Authors:  Rosanna Marsella; Rachel Wilkes; Kim Ahrens
Journal:  Vet Sci       Date:  2022-01-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.